Nomura Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Nomura Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.05M	Sell	33,800 -104,200	-76%	-$6.07M	0.01%	921
2025 Q4	$7.44M	Sell	138,000 -141,300	-51%	-$6.8M	0.01%	640
2025 Q3	$12.6M	Buy	279,300 +71,300	+34%	+$3.33M	0.02%	453
2025 Q2	$9.63M	Buy	208,000 +165,000	+384%	+$8.1M	0.02%	414
2025 Q1	$2.62M	Sell	43,000 -562,700	-93%	-$32.8M	﹤0.01%	950
2024 Q4	$34.3M	Buy	605,700 +540,700	+832%	+$30.2M	0.05%	205
2024 Q3	$3.36M	Hold	65,000	–	–	0.01%	791
2024 Q2	$2.7M	Buy	65,000 +25,000	+63%	+$1.12M	0.01%	854
2024 Q1	$2.17M	Hold	40,000	–	–	0.01%	883
2023 Q4	$2.05M	Sell	40,000 -50,000	-56%	-$2.62M	0.01%	952
2023 Q3	$5.22M	Hold	90,000	–	–	0.01%	521
2023 Q2	$5.76M	Buy	+90,000	New	+$6.04M	0.02%	456
2021 Q1	–	Sell	-45,500	Closed	-$2.74M	–	1901
2020 Q4	$2.74M	Hold	45,500	–	–	﹤0.01%	740
2020 Q3	$2.67M	Hold	45,500	–	–	0.01%	597
2020 Q2	$2.6M	Sell	45,500 -174,100	-79%	-$10.4M	0.01%	506
2020 Q1	$12M	Sell	219,600 -285,900	-57%	-$17.5M	0.05%	201
2019 Q4	$31.2M	Buy	505,500 +298,100	+144%	+$17.1M	0.12%	137
2019 Q3	$10.4M	Sell	207,400 -100,000	-33%	-$4.7M	0.04%	310
2019 Q2	$14.2M	Sell	307,400 -955,300	-76%	-$44.5M	0.06%	253
2019 Q1	$59.6M	Buy	+1,262,700	New	+$62.9M	0.25%	69
2018 Q1	–	Sell	-185,000	Closed	-$11.3M	–	1437
2017 Q4	$11.3M	Hold	185,000	–	–	0.02%	421
2017 Q3	$11.7M	Hold	185,000	–	–	0.02%	342
2017 Q2	$10.3M	Hold	185,000	–	–	0.03%	362
2017 Q1	$10.1M	Sell	185,000 -45,000	-20%	-$2.47M	0.03%	302
2016 Q4	$13.5M	Buy	230,000 +100,000	+77%	+$5.47M	0.03%	304
2016 Q3	$7.06M	Hold	130,000	–	–	0.02%	362
2016 Q2	$9.53M	Buy	130,000 +15,000	+13%	+$1.06M	0.03%	295
2016 Q1	$7.33M	Hold	115,000	–	–	0.02%	274
2015 Q4	$7.92M	Buy	+115,000	New	+$7.6M	0.02%	286
2015 Q1	–	Sell	-71,000	Closed	-$4.14M	–	1793
2014 Q4	$4.14M	Sell	71,000 -1,900	-3%	-$107K	0.01%	682
2014 Q3	$3.73M	Buy	+72,900	New	+$3.64M	0.01%	821
2014 Q2	–	Sell	-14,800	Closed	-$770K	–	2748
2014 Q1	$770K	Buy	+14,800	New	+$788K	﹤0.01%	1587

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nomura Holdings's BMY Position: Q1 2026 in Review

Nomura Holdings reduced its Bristol-Myers Squibb (BMY) stake by 71% in Q1 2026, selling an estimated $2.47M and leaving 17,531 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

Nomura Holdings first reported a position in BMY in Q2 2013 and has held it in 50 quarters since. The position peaked at $133M in Q1 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Nomura Holdings held 17,531 shares of Bristol-Myers Squibb worth $1.06M as of Q1 2026.
Nomura Holdings sold 42,392 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.47M.
Bristol-Myers Squibb made up ﹤0.01% of Nomura Holdings's portfolio in Q1 2026, its #1141 holding.
Nomura Holdings first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 50 quarters since.
Nomura Holdings's Bristol-Myers Squibb position peaked at $133M in Q1 2019.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.